Gluvas M

Indonesia • Dexa Medica

Indication

As an adjunct to diet and exercise in NIDDM (type 2) patients:

  • In case that the monotherapy with glimepiride or metformin do not result in adequate glycemic control
  • Replacement of glimepiride and metformin combination therapy

Composition

  • Metformin 500 mg
  • Glimepiride 2 mg

Package

3 blisters of 10 tablets

Dosage Forms

Tablet

ATC Classification

A10B

Warning

Alcohol
Caution
This item may not be safe for use with alcohol. Use with caution and after consultation with your doctor.
Machinery
Caution
This item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.
Pregnancy
Not Recommended
This item is not safe for use during pregnancy.
Lactation
Not Recommended
This item is not safe for use during lactation.

Dosage

Under 18 Years Old

Safety and effectiveness have not been established.

18 Years Old and Above

The dosage of antidiabetic drugs should be individualized based on the patient’s blood glucose levels. Generally, it should be recommended to initiate the lowest effective dose and increase the dose depending on the patient’s blood glucose levels. Adequate monitoring of blood glucose levels should be performed for this.

It should be administered once or twice per day before or with the meals. When switching from combination therapy of glimepiride plus metformin as separate tablets, GLUVAS M should be administered on the basis of dosage currently being taken.